Abstract：Objective To investigate the recurrence of pulmonary tuberculosis patients 5 years after successful treatment in Hengyang City, Hunan Province, and to analyze its influencing factors. Methods The data of pulmonary tuberculosis patients who were successfully treated in Hengyang City in 2014 were collected through the tuberculosis management information system. The recurrence of pulmonary tuberculosis was defined as the endpoint, and all patients were observed for five consecutive years. Factors affecting recurrence of pulmonary tuberculosis were identified using Kaplan-Meier estimates, log-rank test and multivariable Cox proportional hazards regression analysis. Results A total of 6 626 patients with successfully treated pulmonary tuberculosis were included, including 4 961 males and 1 665 females, with a median age of 54 years. There were 536 cases with recurrence of pulmonary tuberculosis within five years, with a 8.09% cumulative proportion of recurrence and annual recurrence rate of 1.75 per 100 person-years. Multivariable Cox proportional hazards regression analysis showed that men ( HR=1.592, 95%CI: 1.256-2.019 ), age of 40 years and greater ( age of 40 to 59 years, HR=7.025, 95%CI: 1.739-28.377; age of 60 years and greater, HR=8.175, 95%CI: 2.024-33.023), farmers ( HR=1.379, 95%CI: 1.070-1.778 ), retreatment ( HR=6.398, 95%CI: 5.163-7.929 ) and positive etiology ( HR=1.255, 95%CI: 1.042-1.511 ) were risk factors for five-year recurrence of pulmonary tuberculosis among successfully-treated patients. Conclusions High recurrence rate is found among pulmonary tuberculosis patients within five years after successful treatment in Hengyang City. There is a high risk of pulmonary tuberculosis recurrence among male, etiologically positive, retreated farmers at ages of 40 years and older, and targeted interventions are recommended.
[1] World Health Organization.Global tuberculosis report2020[R/OL].[2021-12-27]. https://www.who.int/publications/i/item/9789240013131.pdf. [2] FRANCISCO C,LANSANG M A,SALVANA E M,et al. Multidrug-resistant tuberculosis(MDR-TB)and multidrug-resistant HIV (MDR-HIV) syndemic:challenges in resource limited setting[J/OL]. BMJ Case Rep,2019,12(8)[2021-12-27].http://dx.doi.org/10.1136/bcr-2019-230628. [3] JI Y,SHAO C,CUI Y,et al.18F-FDG positron-emission tomography/computed tomography findings of radiographic lesions suggesting old healed pulmonary tuberculosis and high-risk signs of predicting recurrence: a retrospective study[J]. Sci Rep,2019,9(1):12582-12584. [4] CROFTS J P,ANDREWS N J,BARKER R D,et al.Risk factors for recurrent tuberculosis in England and Wales,1998-2005[J]. Thorax,2010,65(4):310-314. [5] 张屹立,郑晓宇,吴悦.某市2008—2017年结核患者复发因素调查研究[J].中国医药指南,2021,19(11):121-122. ZHANG Y L,ZHENG X Y,WU Y.Investigation and study on the recurrence factors of tuberculosis patients in a certain city from 2008 to 2017[J].Guide China Med,2021,19(11):121-122. [6] 邱玉冰,许琳,杨蕊,等.云南省成功治疗肺结核患者5年复发情况及影响因素研究[J].预防医学,2020,32(6):559-562. QIU Y B,XU L,YANG R,et al.Five-year recurrence rate of tuberculosis and its influencing factors among successfully treated patients in Yunnan Province[J].Prev Med,2020,32(6):559-562. [7] World Health Organization.Definitions and reporting framework for tuberculosis-2013 revision[M]. Geneva:World Health Organization,2014. [8] 林森林,梅建,高谦,等.结核病复发的流行病学研究进展[J].中华流行病学杂志,2013,34(4):409-412. LIN S L,MEI J,GAO Q,et al.Recent advances in the epidemiological research on recurrent tuberculosis[J].Chin J Epidemiol,2013,34(4):409-412. [9] 彭红,虞浩,姜洁,等.江苏省初治结核病复发流行病学特征及影响因素[J].江苏预防医学,2019,30(4):355-359. PENG H,YU H,JIANG J,et al.Epidemiological characteristics and associated factors with tuberculosis recurrence in Jiangsu province[J].Jiangsu Prev Med,2019,30(4):355-359. [10] LEE H,KIM J.A study on the relapse rate of tuberculosis and related factors in Korea using nationwide tuberculosis notification data[J]. Osong Public Health Res Perspect,2014,5(Suppl.):S8-S17. [11] NEYROLLES O,QUINTANA-MURCI L. Sexual inequality in tuberculosis[J/OL]. PLoS Med,2009,6(12)[2021-12-27]. https://doi.org/10.1371/journal.pmed.1000199. [12] SHEN X,YANG C,WU J,et al.Recurrent tuberculosis in an urban area in China:relapse or exogenous reinfection?[J].Tuberculosis,2017,103:97-104. [13] 董振鑫,张思潮.老年涂阳肺结核患者治愈的影响因素分析[J].预防医学,2018,30(11):1142-1144. DONG Z X,ZHANG S C.Associated factors for the cure of elderly smear-positive tuberculosis patients[J].Prev Med,2018,30(11):1142-1144. [14] 戴志松,陈堃,林淑芳,等.福建省成功治疗的肺结核患者10年复发情况及影响因素分析[J].疾病监测,2021,36(11): 1152-1158. DAI Z S,CHEN K,LIN S F,et al.Ten-year recurrence rate in pulmonary tuberculosis patients after successful treatment and influencing factors in Fujian[J].Dis Surveill,2021,36(11):1152-1158. [15] 严碧涯,朱莉贞,汪钟贤,等.第1批肺结核短程化疗研究5年随访报告[J].中国防痨杂志,1993,15(4):166-168. YAN B Y,ZHU L Z,WANG Z X,et al.Five-year follow-up report of the first batch of short-course chemotherapy studies on pulmonary tuberculosis[J].Chin J Antituberc,1993,15(4):166-168.
